Hong Kong Surgical Robot Unicorn Cornerstone Robotics Secures HK$55B Investment from Medtronic
Bastillepost · 1 SOURCESabout 3 hours ago2 MIN
Summary
Hong Kong surgical robotics unicorn Cornerstone Robotics announced on September 2, 2026, a strategic partnership with global medical technology leader Medtronic, securing approximately US$700 million (HK$55 billion) in investment. The collaboration grants Medtronic distribution rights for Cornerstone's domestically developed Sentire endoscopic surgical robot in markets outside the United States. Cornerstone Robotics is a strategic partner of Hong Kong Investment Corporation (HKIC), a wholly government-owned investment vehicle. The deal marks a significant milestone for Hong Kong's innovation and technology sector.
Key Points
- Medtronic invests approximately US$700 million (HK$55 billion) in Hong Kong surgical robotics unicorn Cornerstone Robotics
- Medtronic receives distribution rights for Cornerstone's Sentire endoscopic surgical robot outside the United States
- Cornerstone Robotics is a strategic partner of Hong Kong Investment Corporation (HKIC), the HKSAR government's wholly-owned investment platform
- Sentire received NMPA approval in 2024, EU CE marking and Singapore HSA certification in May 2026
- Certifications cover urology, general surgery, and gynecological minimally invasive procedures
- Matt Anderson, Medtronic Senior Vice President, described Sentire as a strong complement to the Hugo surgical robot platform
Why It Matters
The investment validates Hong Kong's capability to develop world-class surgical robotics technology and positions the city as a biomedical innovation hub. With Medtronic's global distribution network, Sentire can reach international markets faster, potentially making advanced robotic surgery more accessible while creating high-value technology jobs in Hong Kong .
The investment validates Hong Kong's capability to develop world-class surgical robotics technology and positions the city as a biomedical innovation hub. With Medtronic's global distribution network, Sentire can reach international markets faster, potentially making advanced robotic surgery more accessible while creating high-value technology jobs in Hong Kong .